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The immune and central nervous systems are functionally connected
and interacting. The concept that the immune signaling to the brain
which induces fever during infection and inflammation is mediated by
circulating cytokines has been traditionally accepted. Administration
of bacterial lipopolysaccharide (LPS) induces the appearance of a so-
termed cytokine cascade in the circulation more or less concomi-
tantly to the developing febrile response. Also, LPS-like fever can be
induced by systemic administration of key cytokines (IL-1ß, TNF-a,
and others). However, anti-cytokine strategies against IL-1ß or TNF-
a along with systemic injections of LPS frequently lead to attenuation
of the later stages of the febrile response but not of the initial phase of
fever, indicating that cytokines are rather involved in the maintenance
than in the early induction of fever. Within the last years experimental
evidence has accumulated indicating the existence of neural transport
pathways of immune signals to the brain. Because subdiaphragmatic
vagotomy prevents or attenuates fever in response to intraperitoneal or
intravenous injections of LPS, a role for vagal afferent nerve fibers in
fever induction has been proposed. Also other sensory nerves may
participate in the manifestation of febrile responses under certain
experimental conditions. Thus, injection of a small dose of LPS into
an artificial subcutaneous chamber results in fever and formation of
cytokines within the inflamed tissue around the site of injection. This
febrile response can be blocked in part by injection of a local anes-
thetic into the subcutaneous chamber, indicating a participation of
cutaneous afferent nerve signals in the manifestation of fever in this
model. In conclusion, humoral signals and an inflammatory stimula-
tion of afferent sensory nerves can participate in the generation and
maintenance of a febrile response.
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· Central nervous system
Humoral signals and fever:
the relation between circulating
cytokines and the febrile response
After a challenge with an infectious or
inflammatory stimulus somewhere at the pe-
riphery of the body a number of responses
are generated within the CNS. These brain-
mediated signs of illness include changes in
neuroendocrine activities including activa-
tion of the hypothalamic-pituitary-adrenal
(HPA) axis, anorexia and adipsia, changes in
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sleep patterns, decreases in locomotor activ-
ity, libido, social contacts and exploration,
symptoms which are collectively termed sick-
ness behavior, and the development of fever,
a regulated rise of body core temperature (1-
4).
A number of exogenous substances are
capable of evoking fever and the other listed
brain-controlled sickness signs or symptoms
when injected systemically into experimen-
tal animals. Such fever-inducing agents are
called exogenous pyrogens. All these sub-
stances induce the production and release of
immunoregulatory proteins which are gener-
ally termed cytokines. It has been proposed
that circulating cytokines are the endoge-
nous mediators of fever in response to ad-
ministration of an exogenous pyrogen. This
concept about the pathogenesis of fever (2)
is mainly based on three experimental obser-
vations. Lipopolysaccharide (LPS) has been
used as exogenous pyrogen in most experi-
mental studies and therefore focus will be
kept on the events that occur in response to
systemic or local administration of this sub-
stance.
The first set of observations relate to the
appearance of a number of cytokines in the
bloodstream more or less simultaneously to
the development of fever after injection of an
exogenous pyrogen such as LPS from the
cell wall of Gram-negative bacteria. Depend-
ing on the route and injected dose of LPS,
tumor necrosis factor alpha (TNF-a) is the
first cytokine which appears in the circula-
tion (2,5,6), followed by traces of interleu-
kin-1ß (IL-1ß) (5), and high amounts of IL-6
(6,7), IL-8 (8) as well as other cytokines such
as, for example, macrophage inflammatory
protein-1 (MIP-1) (9). A similar cytokine
cascade can be monitored in response to
other pyrogenic compounds of Gram-posi-
tive and Gram-negative bacteria such as su-
perantigens, peptidoglycans or muramyl-
dipeptides. Invading viruses or synthetic vi-
ral compounds activate a distinct pattern of
cytokine production including interferons as
initial mediators within the cytokine cascade
(10). Among all cytokines which are mea-
surable in blood plasma during LPS-induced
fever, circulating levels of IL-6 show the
best correlation with the febrile changes of
body temperature (6,7).
The second set of observations relate to
the fact that fever of similar pattern, extent
and duration as that induced by LPS can also
be induced by peripheral administration of
the same cytokines which are endogenously
released in response to systemic injection of
LPS. Intraperitoneal, intravenous or intra-
arterial injections or infusions of IL-1ß (2,11),
TNF-a (2,12), IL-6 (13), IL-8 (14) or MIP-1
(15) evoke fever in various species of exper-
imental animals. Whether the pyrogenic ef-
fects of these cytokines truly reflect the physi-
ological conditions which are induced by
peripheral injection of LPS is still a matter of
debate (2). It has been argued that the fever-
inducing properties of cytokines may rather
represent pharmacological effects unrelated
to LPS fever (2). Furthermore, it should be
noted that only cytokines such as IL-6 which
are circulating in large amounts during LPS
fever are able to evoke moderate febrile
responses (13), and that the pyrogenic effect
does not manifest itself in all species of
experimental animals as reported for IL-8
(14,16). However, the fact that cytokines
circulating during LPS fever are themselves
pyrogenic in most animal species still sup-
ports the hypothesis that these endogenous
mediators can potentially act as humoral
signals for the brain to induce fever and
other sickness signs in response to infectious
or inflammatory stimulation. The putative
mechanisms of how circulating cytokines
might influence brain structures which are
involved in the manifestation of fever will
be described in the chapter Fever: what
happens within the brain?.
The third body of evidence stems from
experimental procedures which result in an
attenuation of LPS-induced formation of cir-
culating cytokines or in a neutralization of
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the biological activities of a given cytokine
with a concomitant reduction of LPS fever.
TNF-a and IL-1ß are regarded as initial me-
diators within the LPS-induced cytokine cas-
cade. Therefore, most experimental anti-
cytokine strategies are directed against TNF-
a or IL-1ß.
As shown in Figure 1, intra-arterial injec-
tions of 10 µg/kg LPS cause a characteristic
biphasic febrile response in guinea pigs (up-
per panel of Figure 1). Administration of a
dimeric polyethylene glycol-linked form of
the type 1 soluble receptor of TNF, a neutral-
izing TNF-binding protein, abolishes LPS-
induced circulating bioactive TNF and causes
a significant attenuation of the second phase
of the febrile response (17). Intraperitoneal
injection of 30 µg/kg LPS induces a similar
biphasic fever in guinea pigs (lower panel of
Figure 1). Again, the second fever phase can
be depressed by administration of an IL-1
receptor antagonist (IL-1ra). Treatment with
TNF-binding protein or IL-1ra not only at-
tenuates the second phase of LPS fever but
also suppresses circulating levels of IL-6, a
result which confirms that TNF-a and IL-1ß
both contribute to the LPS-induced forma-
tion of systemic IL-6. According to the re-
sults shown in Figure 1, the initial phase of
LPS-induced fever is unimpaired by anti-
TNF or anti-IL-1 strategies in guinea pigs.
These findings suggest that circulating cyto-
kines are not involved in the generation of
the early phase of fever but rather provide
signals which contribute to the maintenance
of the later phase of fever. Such a role for
circulating cytokines is compatible with the
fact that the quick onset of LPS fever (3) or
LPS-induced activation of the HPA axis (18)
seems to precede the systemic formation of
considerable amounts of these pyrogenic
cytokines.
If the first phase of LPS fever develops
independently of circulating TNF-a, IL-1ß,
IL-6, IL-8 or MIP-1, what kind of signal then
mediates the quick onset of the early stage of
fever? One possibility which has been dis-
cussed in this context is the existence of a
preformed pyrogenic factor (PFPF) which is
continuously present in macrophages and
can be released immediately after LPS stim-
ulation (19). Also, pyrogenic substances
which can be induced by LPS within sec-
onds or minutes such as complement frag-
ments have been proposed as endogenous
humoral signals for induction of the early
phase of fever (3,20). Finally, it has been
Figure 1 - Upper panel, Febrile response, measured as abdominal temperature (Tabd), of
two groups of guinea pigs to intra-arterial injections of 10 µg/kg LPS together with 1 mg
TNF-binding protein (TNF-bp, N = 8) or solvent (N = 9) per animal. Modified from Ref. 17
with permission from The Physiological Society. Lower panel, Febrile response of two
groups of guinea pigs to intraperitoneal injections of 30 µg/kg LPS together with 3 mg IL-1
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speculated that a direct action of LPS on
brain endothelial cells via activation of an
ancient toll-like receptor which belongs to
the IL-1 receptor family might contribute to
the quick induction of fever (21).
An alternative and rapid communication
pathway between the activated immune sys-
tem and those parts of the brain which are
involved in fever induction would be via
stimulation of afferent nerves. Within the
last 5 years a number of studies have fo-
cussed on this topic.
Afferent neural signals and fever:
the role of the vagus nerve
Evidence for a role of the vagus nerve as
a vehicle for transfer of peripheral immune
signals to the brain derives from observa-
tions that transection of the abdominal trunks
of the vagus nerve (subdiaphragmatic va-
gotomy) attenuates or even abrogates a num-
ber of illness responses to intraperitoneal or
intravenous injections of moderate doses of
bacterial LPS or proinflammatory cytokines.
Sickness behavior induced by intraperito-
neal injections of pyrogens is prevented in
vagotomized animals (22). The LPS-induced
activation of the HPA axis (23), hyperalge-
sia (24) or increase of slow-wave sleep (25)
are all attenuated by subdiaphragmatic va-
gotomy. Even the LPS-induced expression
of the c-Fos and IL-1ß genes within the brain
is depressed in vagotomized rats or mice
(26,27). Suppression of LPS fever after va-
gotomy has been reported for guinea pigs
(3,28) and rats (29), but this phenomenon
seems to depend on the injected dose of LPS
(29) and on the route of LPS administration
(28). One study even reported that subdia-
phragmatic vagotomy failed to cause a sig-
nificant suppression of fever (30). An ex-
ample from experiments in vagotomized
guinea pigs is shown in Figure 2.
The upper panel of Figure 2 shows the
effect of intraperitoneal injection of LPS on
the abdominal temperature of vagotomized
and sham-operated guinea pigs. Subdiaphrag-
matic vagotomy results in a significant sup-
pression of LPS fever as long as the pyrogen
is injected by the intraperitoneal route. The
lower panel of Figure 2 shows that intramus-
cular injection of LPS results in identical
fever in both vagotomized and sham-
operated guinea pigs. Vagal afferent fibers
thus seem to play a role in the transduction
Figure 2 - Upper panel, Effects of intraperitoneal (ip) injections of 30 µg/kg LPS on the
abdominal temperature (Tabd) of vagotomized (N = 7) and sham-operated (N = 6) guinea
pigs. Lower panel, Effects of intramuscular (im) injections of 20 µg/kg LPS on the Tabd of
vagotomized (N = 7) and sham-operated (N = 6) guinea pigs. (Reprinted from Ref. 28 with
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of immune signals from the abdominal
cavity to the brain. Apparently, however, it
is possible to bypass the vagal communica-
tion pathway between the immune system
and the brain, otherwise vagotomized guin-
ea pigs would not develop unimpaired fever
in response to intramuscular LPS injection.
This finding is supported by another study
showing that sickness behavior induced
by IL-1 is suppressed in vagotomized
rats only if the cytokine is injected by the
intraperitoneal route but not by other routes
(22).
Subdiaphragmatic vagotomy is a drastic
procedure which interrupts both afferent and
efferent fibers of the vagus nerve and may
disturb vital homeostatic functions. There-
fore, the question arises if there are addi-
tional arguments that support a role of the
vagus nerve as a pathway for transmission of
immune signals to the brain. Direct evidence
for a stimulation of afferent fibers of the
vagus nerve by immune signals derives from
the observation that injection of IL-1ß into
the portal vein at physiological doses of 10
or 100 pg per animal results in a significant
increase of the firing rate of the vagal hepatic
afferent nerve branch (31). Furthermore, glo-
mus cells of vagal paraganglia are labeled
with a biotinylated IL-1 receptor antagonist,
indicating binding sites for IL-1 on the mem-
branes of these cells (32). Finally, intraperi-
toneal administration of bacterial LPS (33)
induces c-Fos immunoreactivity in primary
afferent neurons of the vagus nerve. This
protein product of the immediate early gene
c-Fos indicates a rapid activation of these
neurons in response to LPS. The activation
of vagal afferent fibers (31) and of primary
afferent neurons of the vagus nerve (33) by
immune stimuli may thus provide direct ev-
idence that vagal afferents, together with
other mechanisms, transmit signals from the
activated immune system to the brain to
induce a number of brain-controlled sick-
ness symptoms which accompany peripher-
al infection or inflammation.
Afferent neural signals and fever:
a role for cutaneous sensory nerves?
Accepting that afferents from the vagus
nerve serve to transport signals from the
activated immune system from the perito-
neum to the brain, the question then arises if
afferents from cutaneous nerves may repre-
sent a neural route for immune-to-brain com-
munication. The investigation of this ques-
tion requires an experimental model which
compromises local cytokine induction within
a localized subcutaneous compartment and a
developing febrile response or modifications
of other brain-controlled functions. Such a
model has been introduced into experimen-
tal fever research over the last few years. In
rats, injection of LPS into a subcutaneous air
pouch results in fever and a local formation
of cytokines (34,35). Of the proinflamma-
tory cytokines, which can be detected in the
air pouch lavage in response to administra-
tion of LPS, only small amounts of IL-6
enter the systemic circulation from the site
of inflammation (34). Recently, the subcuta-
neous air pouch model was evaluated in
guinea pigs (36,37). Essentially the same
results were obtained as those obtained with
rats (34,35). In one of our studies on guinea
pigs the air pouch was replaced with a sub-
cutaneously placed Teflon chamber equipped
with a catheter (37). The cylindric chambers,
opened at both ends, were implanted into
preformed subcutaneous cavities. The open
sides of the chambers were in close contact
with the skin tissue (for details, see 37). This
approach allowed administration of drugs
into the chamber through the catheter and
repeated collections of lavage fluid from the
chamber. An intra-arterial catheter allowed
the collection of blood samples. Using this
model, we analyzed the febrile responses to
injections of high (100 µg/kg) and low (10
µg/kg) doses of LPS into the chamber. A
local anesthetic, ropivacaine, was also ad-
ministered into the chamber. Levels of pro-
inflammatory cytokines in the systemic cir-
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culation and in lavage fluid collected from
the chamber were monitored.
The magnitude of fever in different groups
is represented in the columns of Figure 3 as
the integrated areas between thermal re-
sponses of febrile and normothermic ani-
mals. The mean body temperature measured
at 15-min intervals over the 2 h before injec-
tion of LPS or control solutions was calcu-
lated as the baseline temperature (Figure 1).
The mean magnitude of the fever which
develops in response to injection of 100 µg/
kg LPS into the subcutaneous Teflon cham-
ber was defined as 100% fever response. Co-
administration of 10 mg/kg of the local anes-
thetic ropivacaine into the chamber appar-
ently has no influence on the febrile re-
sponse to this dose of LPS. A reduction of
the LPS dose to 10 µg/kg caused a smaller
fever when injected into the subcutaneous
chamber. Interestingly, the febrile response
to the low dose of LPS was markedly re-
duced by co-injection of ropivacaine (10
mg/kg) into the chamber. A systemic action
of the local anesthetic may be ruled out
since, when injected subcutaneously on the
contralateral side of the animal (in Figure 3)
in relation to the chamber at the same dose, it
failed to alter the fever induced by the low
dose of LPS. This result suggests that affer-
ent neural signals which are blocked by the
local anesthetic in the chamber may partici-
pate in the transmission of febrile signals
from a localized site of peripheral inflamma-
tion, in this case the subcutaneous chamber,
to parts of the brain which control the ther-
moregulatory set point and are involved in
fever induction. Support for this hypothesis
is given by other studies in which an impair-
ment of afferent C fibers by capsaicin desen-
sitization significantly attenuated pyrogen-
induced fever and HPA axis activation (38,
39).
Assuming that localized peripheral in-
flammation alters the activity of cutaneous
afferent fibers, further questions arise: why
was not the febrile response to the high dose
of LPS altered by treatment with ropivacaine?
Which kind of signal was responsible for the
part of the febrile response to the low dose of
LPS which was not blocked by the local
anesthetic? Regarding the first question, it is
possible that LPS when injected at high doses
may leave the compartment (e.g., via circu-
lation) and provoke systemic or local re-
sponses in other tissues. It must be remem-
bered that in vagotomized rats the febrile
effect of intraperitoneal LPS, mainly at high
doses, is not always blocked (29) and that
the pyrogen may induce fever when injected
in other compartments of vagotomized ani-
mals. Using the Limulus amebocyte lysate
assay we recently obtained evidence that,
with the exception of few animals treated
with a high LPS dose, LPS does not appear in
the circulation of guinea pigs after its injec-
tion into the subcutaneous chamber. Exclud-
ing the possibility of LPS reaching the sys-
temic circulation, other interpretations may
be examined. A possible answer to both
questions raised above is that neural signals
Figure 3 - Integrated fever response (area under the fever curve calculated for 6 h) in 7
groups of guinea pigs after injection into implanted subcutaneous chambers of saline (NaCl,
N = 5), 10 mg/kg ropivacaine (ROPI, N = 5), 100 µg/kg LPS together with saline (LPS 100, N
= 6), 100 µg/kg LPS together with 10 mg/kg ropivacaine (ROPI + LPS 100, N = 6), 10 µg/kg
LPS together with saline (LPS 10, N = 7), 10 µg/kg LPS together with 10 mg/kg ropivacaine
(ROPI + LPS 10, N = 7) or 10 µg/kg LPS together with 10 mg/kg ropivacaine into the
subcutaneous tissue contralateral (c.l.) to the chamber position (ROPI c.l. + LPS 10, N = 6).
The mean fever response of the group which received 100 µg/kg LPS together with saline
















































































NaCI ROPI LPS 100 ROPI +
LPS 100






Braz J Med Biol Res 34(3) 2001
Pathways for fever induction
can be activated by inflammatory stimuli but
provide a moderate portion of the informa-
tion which is transmitted to the brain to
induce fever. The other portion of the febrile
signal, probably provided by humoral sig-
nals, would totally override the neuronal
component in the case of high LPS doses.
The humoral component, in the case of a
high dose of LPS, may be depicted as a
spillover of endogenous mediators into the
systemic circulation. The search for humoral
mediators involved in fever induction in the
subcutaneous chamber or the air pouch
focusses on the cytokine IL-6. Measurements
(19,37) confirming previous observations
(34) showed a moderate increase of IL-6, but
not of IL-1 or TNF in the systemic circula-
tion after LPS injection into the chamber or
air pouch. Recently, the authors of the latter
study (34) provided convincing experimen-
tal evidence that the rise of circulating IL-6
in response to LPS injection in the subcuta-
neous air pouch in rats is due to a spillover of
this cytokine from the local site of inflamma-
tion into the systemic circulation and that the
increase of IL-6 in the bloodstream, albeit
moderate, is involved in the manifestation of
fever (40). However, it should be noted that
a high LPS dose (100 µg/kg) was used in the
rat air pouch (19,34). Fever in response to
the same dose of LPS in the subcutaneous
chamber of the guinea pig could not be an-
tagonized by treatment with the local anes-
thetic ropivacaine (Figure 3). Thus, our find-
ings support the view that fever in response
to the high dose of LPS (100 µg/kg) is,
indeed, mostly mediated by humoral signal
transmission. IL-6 which enters the circula-
tion from the local site of inflammation is a
likely candidate for a humoral signal mole-
cule for fever induction (40). The circulating
cytokine could stimulate vascular sensory
fibers throughout the circulatory compart-
ment or directly stimulate the brain as dis-
cussed in the next chapter. The attenuation
of fever induced by the lower dose of LPS
(10 µg/kg) by administration of ropivacaine
at the site of inflammation at present can be
interpreted as modest evidence for the par-
ticipation of a neural pathway in fever induc-
tion from a site of locally induced inflamma-
tion within the subcutaneous chamber to the
thermoregulatory centers of the brain.
Fever: what happens within the brain?
As illustrated above there is evidence for
both humoral and neural signaling from the
immune system to the brain in the presence
of a peripheral inflammatory stimulus. The
following topics are addressed in this chap-
ter:
i) How do humoral or neural signals ac-
cess those parts of the brain which are in-
volved in the febrile shift of the thermoregu-
latory set point?
ii) Are endogenous brain-derived signal
molecules the final mediators of fever and
which molecules are the most likely candi-
dates for this function?
Entry of humoral or neural signals into the
brain
Accepting that circulating cytokines are
important humoral mediators for the induc-
tion or at least maintenance of fever, the
question arises of how these large hydro-
philic peptides pass the relatively imperme-
able blood-brain barrier to stimulate relevant
thermoregulatory brain structures. On the
one hand, there is experimental evidence
that peripheral cytokines can pass the blood-
brain barrier by active and saturable trans-
port systems which are specific for indi-
vidual cytokines (41). An alternative hu-
moral pathway is the access of cytokines
through areas of the brain which lack a tight
blood-brain barrier. These areas are the so-
termed circumventricular organs. A role for
the circumventricular organs in fever has
especially been ascribed to the organum
vasculosum laminae terminalis and the sub-
fornical organ (3,4,42). At these sites circu-
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lating cytokines might enter the perivascular
space and interact with receptors located at
terminals of glial cells. Also, receptors on
the surface of endothelial cells in brain vas-
culature are potential targets for circulating
cytokines or even LPS (21). Glial cells and
endothelial cells might then produce and
release secondary mediators (see below)
which are released into the brain and can
thus obtain access to thermoregulatory struc-
tures within the preoptic area and hypotha-
lamic nuclei which are involved in body
temperature regulation.
The proposed pathway of how sensory
nerves, namely afferents of the vagus nerve,
transmit signals to the relevant hypothalam-
ic areas has been recently described (3,20)
and can be summarized as follows. The ap-
pearance of LPS in the bloodstream leads to
a rapid complement activation within min-
utes. Components of the complement cas-
cade stimulate Kupffer cells of the liver to
produce further endogenous mediators, most
likely cytokines, which are able to activate
afferent fibers of the hepatic branch of the
vagus nerve (3). The signals of hepatic vagal
afferents are transported to the central pro-
jection areas of the vagus nerve within the
nucleus of the solitary tract. The pyrogenic
message is then passed to the noradrenergic
A1/A2 cell groups which are located in this
brainstem area and project directly to preop-
tic and hypothalamic areas via the ventral
noradrenergic bundle (for further details of
this hypothesis, see 3,20).
Final fever-inducing mediators in the
thermoregulatory centers of the brain
A large number of neurons located in the
rostral hypothalamus are thermosensitive.
Several endogenous inflammatory media-
tors cause changes in the activity of these
neurons which are consistent with the devel-
opment of fever, i.e., an inhibition of heat-
sensitive neurons or a stimulation of the few
cold-sensitive neurons which exist within
the preoptic/hypothalamic areas (43). These
findings were obtained in ex vivo protocols
by registering neuronal firing rates in rat
brain slices at changing temperatures and in
the presence of superfusion with cytokines.
Considering that such neuronal mechanisms
account for the febrile response to peripheral
injection of LPS, it may be postulated that
thermosensitive neurons of the brain are ex-
posed to one or more of these endogenous
mediators at the onset of the febrile response.
Therefore, intensive research has been fo-
cussed on the question as to which putative
fever-promoting substances are produced and
released within the brain in response to pe-
ripheral administration of LPS. While pe-
ripheral injections of septic doses of LPS
induce global expression of proinflamma-
tory cytokines in the brain, subseptic - but
fever-inducing - LPS doses seem to induce
expression of IL-1ß and TNF-a only in the
choroid plexus, the meninges and the cir-
cumventricular organs which are implicated
in fever (44,45). The organum vasculosum
laminae terminalis at the anterior wall of the
third ventricle has been identified as a site of
production of IL-1ß and TNF-a in response
to peripheral injection of a moderate dose of
LPS (44,45). The organum vasculosum lami-
nae terminalis is located close to the sur-
rounding preoptic area so that a diffusion of
pyrogenic mediators to the thermosensitive
structures is apparently possible. Alterna-
tively, the endothelium of the cerebral vas-
culature may be the site where circulating
cytokines or LPS could interact with recep-
tors and stimulate the endothelial cells to
release additional cytokines or other second-
ary mediators abluminally into the brain. For
example, IL-6 (5-7), IL-8 (16) and MIP-1
(46) are produced and released within the
brain in response to peripheral LPS and a
central pyrogenic activity of these cytokines
has been demonstrated (2,7,13,16,19,47).
Especially, the appearance and biological
action of IL-6 within the brain seem to be a
critical component of fever generation as
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convincingly demonstrated in a study using
IL-6-deficient (IL-6 knockout) mice (48).
In these mice neither peripheral injections of
LPS and IL-1ß nor central administration of
IL-1ß cause fever while intracerebroventricu-
lar injection of IL-6 evokes a pronounced
febrile response. The results of this study
indicate that central IL-6 is a crucial compo-
nent of fever which acts downstream from
peripheral and central IL-1ß (48).
Not only cytokines but also other puta-
tive endogenous mediators which are in-
volved in fever are produced in the brain in
response to peripheral injection of LPS. Bac-
terial LPS and proinflammatory cytokines
induce or up-regulate a number of enzymes
in the brain which catalyze the formation of
small signal molecules such as nitric oxide
(NO), carbon monoxide (CO) and prosta-
glandin E2 (PGE2). There is experimental
evidence that these substances modulate neu-
ronal activity and are thereby able to alter
thermoregulatory characteristics in a direc-
tion which is consistent with the generation
of fever. NO as well as CO are produced by
constitutive and inducible forms of specific
enzymes, NO synthases and heme oxygena-
ses, and both act on the cellular level via
activation of soluble guanylate cyclase lead-
ing to increased cGMP levels. In some ex-
perimental models NO and CO have been
shown to promote the development of fever
(49,50). However, the described effects of
NO on thermoregulation and fever are not
consistent in all investigated species of ex-
perimental animals (49). In contrast to the
comparatively novel central nervous mes-
senger molecules NO and CO, PGE2 is tra-
ditionally regarded as a centrally acting me-
diator of fever. The formation of PGE2 de-
pends on the activity of cyclooxygenase
(COX) which exists in two isoforms, the
constitutively expressed COX-1 and the in-
ducible form COX-2. The induction of COX-
2, measured by mRNA or protein expres-
sion, in response to peripheral injection of a
fever-inducing dose of LPS can be demon-
strated in brain endothelial cells, perivascu-
lar microglia and meningeal macrophages
(51,52). The production of PGE2 via induc-
tion of COX-2 or via constitutive COX-1
may be an important step in the manifesta-
tion of the febrile response to LPS. Such a
view is supported by the following findings.
Central injection of prostaglandins evokes
fever (2-4). The levels of PGE2 in the cere-
brospinal fluid from the third ventricle (53)
and in microdialysis samples from the pre-
optic area/anterior hypothalamus (3) rise
more or less in parallel to the LPS-induced
changes of body temperature. Drugs which
block prostaglandin synthesis also effectively
inhibit the febrile response (2-4). Finally,
knockout mice which are lacking one of the
four PGE receptors, the EP-3 receptor (54),
show impaired fever in response to peripher-
al injection of LPS. Because of the strong
evidence for an important role of central
PGE2 in fever, the following chain of events
has been frequently suggested: LPS appear-
ing in the blood induces circulating cyto-
kines. Then, circulating cytokines and LPS
induce another source of cytokines as well as
COX-2 within the brain. Centrally produced
cytokines are further triggers for COX-2 in-
duction and thereby for prolonged formation
of PGE2 within the preoptic area and the
hypothalamus. However, it should be noted
that there are some exceptions in which fe-
ver develops independently from prostaglan-
dins. Thus, prostaglandins are obviously not
involved in MIP-1- (15), IL-8- (16), PFPF-
(19), substance P- (55) or endothelin-1 (56)-
induced fever.
There is also evidence for the recruit-
ment of final brain-derived pyrogenic me-
diators of fever which are produced and
released in response to stimulation of affer-
ent fibers of the vagus nerve. Thus, subdia-
phragmatic vagotomy blocks the LPS-in-
duced induction of IL-1ß mRNA in the brain
(27). In turn, electrical stimulation of the
vagus nerve induces IL-1ß expression within
the hypothalamus (57). IL-1ß is not the only
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molecule the LPS-induced expression of
which is blocked in the hypothalamus of
vagotomized animals. It was recently shown
that intraperitoneally injected LPS (50 µg/
kg) induced fever and kinin B1 receptor
mRNA expression in the rat hypothalamus
(58). Subdiaphragmatic vagotomy blocked
both fever and B1, but not B2 kinin receptor
or ß-actin mRNA expression, suggesting a
participation of central hypothalamic kinins
in the pyrogenic response to LPS (Figure 4,
Ref. 58).
The upper panel of Figure 4 shows that
intraperitoneal injection of 50 µg/kg LPS
induced the expression of mRNA for B1
kinin receptors in the rat hypothalamus.
mRNA was detected by RT-PCR in the rat
hypothalamus 6 h after intraperitoneal injec-
tion of LPS. The hypothalami were dissected
and stored at -80oC. cDNA was obtained by
reverse transcriptase reaction with a poly-T
primer from purified hypothalamic mRNA.
Kinin B1 and B2 receptor cDNA and ß-actin
cDNA were amplified with specific primers
and the reaction products were visualized in
ethidium bromide-stained gels. mRNA for
B2 receptors (and ß-actin), which is consti-
tutively expressed, was present in sham and
vagotomized animals whether they received
saline or LPS. However, the kinin B1 recep-
tor mRNA after LPS was present in sham-
operated but not in vagotomized animals.
These results suggest that ascending vagal
inputs mediate kinin B1 receptor mRNA
expression in the hypothalamus after periph-
eral injection of LPS and that newly ex-
pressed hypothalamic B1 receptors may par-
ticipate in the central mechanism for fever
development (58). These and other findings
are important evidence for an ascending va-
gal pathway in the mediation of fever and the
expression of receptors and/or mediators in
the hypothalamus.
Once more prostaglandins seem to be
critical final mediators in the vagally acti-
vated fever pathway since bradykinin-in-
duced fever is blocked by indomethacin, a
COX-1 and COX-2 inhibitor (Figure 4). So,
one can suppose that local mediators, cyto-
kines and possibly PFPF, released in the
peritoneum stimulate the vagus nerve, which
in turn would promote the expression of B1
receptors. By acting on its constitutive B2
and newly expressed B1 receptors, bradyki-
nin could trigger prostaglandin synthesis,
which would act as one of the final media-
tors of fever. Moreover, as already men-
Figure 4 - Upper panel, Effect of vagotomy on the expression of kinin B1 and B2 receptor
mRNA in rat hypothalami. The expression of mRNA for the kinin B1 receptor in the rat
hypothalamus was induced by intraperitoneal injection of LPS (50 µg/kg). mRNA was
detected by RT-PCR in rat hypothalami 6 h after the stimulus. Lower panel, Effect of
indomethacin (IND) on the rectal temperature change caused by intracerebroventricular (icv )
injection of bradykinin (BK). Bradykinin (10 nM) was injected 30 min after intraperitoneal (ip)
treatment with indomethacin (2 mg/kg) or Tris buffer. CSF, Cerebrospinal fluid; VL, va-
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tioned above (3), the inflammatory stimula-
tion of afferent parts of the vagus nerve to
their central projection areas seems to result
in an activation of the ventral noradrenergic
bundle which results in an increased release
of noradrenaline within the preoptic/hypo-
thalamic area. Indeed, an increased intrahy-
pothalamic release of noradrenaline is mea-
surable in response to peripheral administra-
tion of LPS (59). Based on the observation
that microdialysis of noradrenaline into the
hypothalamus augments the local intrahypo-
thalamic production of PGE2 and that the
LPS-induced rise of hypothalamic PGE2 is
blocked by subdiaphragmatic vagotomy (3),
the proposition that hypothalamic PGE2 is
also an important endogenous mediator in
the vagally mediated fever pathway is rein-
forced.
The ability of some cytokines (except
TNF-a and IL-1a) and PGF2a to induce
fever seems to be related to the generation of
corticotropin-releasing hormone (CRH)
within the brain since the increase in body
temperature induced by these substances is
abolished by the CRH antagonist, a-helical
CRH9-41 (19,60). Moreover, the increase in
noradrenaline turnover in the rat hypothala-
mus caused by intraperitoneally injected IL-
1ß is blocked by a polyclonal anti-CRH anti-
body (61). These findings show that IL-1ß
can activate CRH neurons that connect with
the noradrenergic neurons projecting to the
hypothalamus (61). Interestingly, subdia-
phragmatic vagotomy suppressed c-Fos ex-
pression in CRH neurons and the plasma
ACTH and corticosterone response after in-
traperitoneal injection of a low, but not a
high, dose of LPS, showing that vagal affer-
ents are involved in the activation of the
HPA axis (23), a parallel characteristic sig-
nal of fever in the acute phase response.
Final conclusions
The current evidence for distinct path-
ways of fever induction in response to pe-
ripheral inflammatory stimulation was sum-
marized. Induction and regulation of fever
result from complex bilateral communica-
tion between the immune system and the
peripheral and central nervous system. Fig-
ure 5 schematically shows the communica-
tion pathways for which experimental evi-
dence was presented (see Figures 1-4).
Immune cells which are activated by ex-
ogenous pyrogens, i.e., LPS, release a num-
ber of soluble mediators including proin-
flammatory cytokines which coordinate the
immune defense responses. Cytokines can
stimulate afferent sensory nerves or when
released into the bloodstream can activate
the CNS via circumventricular organs
through their fenestrated capillaries or di-
rectly stimulate brain vascular endothelial
cells. The formation of peripheral cytokines
in response to LPS as well as the humoral
signal transfer into the CNS requires some
time. The quick onset of LPS fever seems to
precede the formation of sufficiently high
amounts of circulating cytokines, at least in
some experimental fever models (3). In ad-
dition, as shown in Figure 1, systemic anti-
cytokine strategies predominantly attenuate
the second phase of LPS fever. Thus, it
seems that the peripheral release of cyto-
Figure 5 - Schematic illustration
of pathways for bilateral com-
munication between the im-
mune system and the central
nervous system (CNS). CVOs =
Circumventricular organs; PGE =
prostaglandin E. For further de-
tails, see text. (Reprinted from
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kines rather contributes to the maintenance
of fever than to the induction of the early
phase of fever. These observations and the
fact that fever can sometimes occur in the
absence of circulating cytokines support the
view that also a localized formation of cyto-
kines or other rapidly inducible pyrogenic
factors can activate alternative fever path-
ways. Postulated neuronal mechanisms of
pyrogen signaling to the brain could explain
the quick onset of fever. Two examples of
fever pathways in which neuronal routes are
involved are also indicated in Figure 5. For
the stimulation of afferent parts of the para-
sympathetic system (vagus nerve) by inflam-
matory signals a lot of experimental evi-
dence has accumulated. The results shown
in Figure 3 provide a first modest amount of
evidence that also cutaneous afferent nerves
might participate in the fever response which
develops after subcutaneously localized tis-
sue inflammation. These results can be inter-
preted as a participation of afferent nerves in
a sensory host-monitoring system that rap-
idly informs the brain about a challenge to
the immune system somewhere at the pe-
riphery of the body.
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